title: Dopamine agonist monotherapy in early Parkinson's disease.
abstract: While levodopa therapy for Parkinson's disease is still considered the gold standard, motor complications are significant disadvantages of treatment. Monotherapy with dopamine agonists may present an alternative approach with a reduced likelihood of developing dyskinesias. Further studies are required before a definitive judgment can be made.
authors.affiliation: Department of Neurology, City Hospital and University of Birmingham, Birmingham B18 7QH.
authors.forename: C E
authors.initials: CE
authors.lastname: Clarke
mesh_terms: D002986:Clinical Trials as Topic; D003952:Diagnostic Imaging; D018492:Dopamine Antagonists / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*
chemical_list: D018492:Dopamine Antagonists